Propylparaben Sodium
CAS 35285-69-9
Propylparaben Sodium (CAS 35285-69-9) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| SODIUM PROPYLPARABEN | 1311574 | SU | MTHSPL |
| PROPYLPARABEN SODIUM | 1311574 | SU | MTHSPL |
| Propylparaben Sodium | 1311574 | SU | MTHSPL |
| propylparaben sodium | 1311574 | SU | MTHSPL |
| propylparaben sodium | 1311574 | PIN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Propylparaben Sodium used for in pharmaceutical contexts?
Propylparaben Sodium (CAS 35285-69-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Propylparaben Sodium?
No adverse-event association or SIDER side-effect rows are rendered for Propylparaben Sodium in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Propylparaben Sodium also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Sodium Propylparaben with EU status "permitted".
What clinical phase is Propylparaben Sodium in?
No phase 1-4 clinical development badge is rendered for Propylparaben Sodium because the matched compound identifier rows do not contain a max-phase value.